Price T Rowe Associates Inc Astrazeneca PLC Transaction History

Price T Rowe Associates Inc

  • $812 Billion
  • Q1 2025

A detailed history of Price T Rowe Associates Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Price T Rowe Associates Inc holds 57,086,881 shares of AZN stock, worth $3.99 Billion. This represents 0.52% of its overall portfolio holdings.

Number of Shares
57,086,881
Previous 60,351,973 5.41%
Holding current value
$3.99 Billion
Previous $3.95 Billion 6.11%
% of portfolio
0.52%
Previous 0.46%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$65.37 - $77.96 $213 Million - $255 Million
-3,265,092 Reduced 5.41%
57,086,881 $4.2 Billion
Q4 2024

Feb 14, 2025
SELL
$63.2 - $79.58 $161 Million - $202 Million
-2,540,609 Reduced 4.04%
60,351,973 $3.95 Billion
Q3 2024

Nov 14, 2024
SELL
$76.67 - $87.62 $157 Million - $179 Million
-2,047,079 Reduced 3.15%
62,892,582 $4.9 Billion
Q2 2024

Aug 14, 2024
BUY
$66.81 - $80.83 $245 Million - $296 Million
3,667,687 Added 5.99%
64,939,661 $5.06 Billion
Q1 2024

May 15, 2024
BUY
$61.03 - $69.57 $549 Million - $626 Million
9,002,450 Added 17.22%
61,271,974 $4.15 Billion
Q4 2023

Feb 14, 2024
SELL
$61.89 - $69.28 $91.3 Million - $102 Million
-1,475,163 Reduced 2.74%
52,269,524 $3.52 Billion
Q3 2023

Nov 14, 2023
BUY
$64.85 - $71.7 $58.3 Million - $64.5 Million
899,089 Added 1.7%
53,744,687 $3.64 Billion
Q2 2023

Aug 14, 2023
SELL
$69.91 - $75.81 $418 Million - $453 Million
-5,972,371 Reduced 10.15%
52,845,598 $3.78 Billion
Q1 2023

May 15, 2023
SELL
$63.15 - $71.6 $617 Million - $700 Million
-9,773,679 Reduced 14.25%
58,817,969 $4.08 Billion
Q4 2022

Feb 14, 2023
SELL
$54.21 - $70.44 $368 Million - $479 Million
-6,793,368 Reduced 9.01%
68,591,648 $4.65 Billion
Q3 2022

Nov 14, 2022
SELL
$53.02 - $135.75 $559 Million - $1.43 Billion
-10,534,780 Reduced 12.26%
75,385,016 $4.14 Billion
Q2 2022

Aug 15, 2022
SELL
$59.26 - $71.14 $492 Million - $591 Million
-8,310,073 Reduced 8.82%
85,919,796 $5.68 Billion
Q1 2022

May 16, 2022
BUY
$55.72 - $67.12 $245 Million - $295 Million
4,389,118 Added 4.89%
94,229,869 $6.25 Billion
Q4 2021

Feb 14, 2022
BUY
$54.02 - $63.83 $406 Million - $480 Million
7,518,229 Added 9.13%
89,840,751 $5.23 Billion
Q3 2021

Nov 15, 2021
BUY
$55.56 - $60.79 $798 Million - $874 Million
14,370,118 Added 21.15%
82,322,522 $4.94 Billion
Q2 2021

Aug 16, 2021
BUY
$48.42 - $60.18 $480 Million - $596 Million
9,905,274 Added 17.06%
67,952,404 $4.07 Billion
Q1 2021

May 17, 2021
BUY
$47.16 - $54.44 $1.86 Billion - $2.15 Billion
39,450,439 Added 212.14%
58,047,130 $2.89 Billion
Q4 2020

Feb 16, 2021
BUY
$48.52 - $58.02 $902 Million - $1.08 Billion
18,596,691 New
18,596,691 $930 Million

Others Institutions Holding AZN

# of Institutions
1,427
Shares Held
504M
Call Options Held
10M
Put Options Held
3.14M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $217B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email